SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-224579
Filing Date
2019-08-19
Accepted
2019-08-19 17:27:06
Documents
12
Period of Report
2019-08-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d793259d8k.htm 8-K 39497
2 EX-1.1 d793259dex11.htm EX-1.1 442314
3 EX-3.1 d793259dex31.htm EX-3.1 76508
4 EX-4.1 d793259dex41.htm EX-4.1 100724
5 EX-4.2 d793259dex42.htm EX-4.2 101274
6 EX-5.1 d793259dex51.htm EX-5.1 14489
7 EX-10.1 d793259dex101.htm EX-10.1 436893
8 EX-99.1 d793259dex991.htm EX-99.1 10679
9 EX-99.2 d793259dex992.htm EX-99.2 10863
10 GRAPHIC g793259g12f49.jpg GRAPHIC 9706
11 GRAPHIC g793259snap0001.jpg GRAPHIC 3182
12 GRAPHIC g793259snap1.jpg GRAPHIC 8577
  Complete submission text file 0001193125-19-224579.txt   1264660
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 191037339
SIC: 2834 Pharmaceutical Preparations